Log in
Enquire now

List of SBIR/STTR awards granted to Chrysalis Biotherapeutics, Inc.

List of SBIR/STTR awards granted to Chrysalis Biotherapeutics, Inc.
List of SBIR/STTR awards granted to Judd Systems Technologies, LLC
List of SBIR/STTR awards granted to Viewpoint Molecular Targeting, Inc.
List of SBIR/STTR awards granted to Novelmed Therapeutics Inc
List of NextVPU (Shanghai) Co., Ltd. patents
List of BACKED VC portfolio companies
where
SBIR/STTR Award Recipient
is
‌
Chrysalis Biotherapeutics, Inc.
Name
Description
SBIR/STTR Award Recipient
Government Agency
Government Branch
Award Type
Contract Number (US Government)
Award Phase
Award Amount (USD)
Date Awarded
Official Website
‌
Chrysalis BioTherapeutics, Inc. SBIR Phase II Award, April 2016

A SBIR Phase II contract was awarded to Chrysalis Biotherapeutics, Inc. in April, 2016 for $3,000,000.0 USD from the U.S. Department of Health & Human Services.

‌
Chrysalis Biotherapeutics, Inc.
SBIR
2R44AI086135-05
Phase II
3,000,000
April 15, 2016
sbir.gov/node/1164705
‌
Chrysalis BioTherapeutics, Inc. SBIR Phase II Award,

A SBIR Phase II contract was awarded to Chrysalis Biotherapeutics, Inc. for $2,789,079.0 USD from the U.S. Department of Health & Human Services.

‌
Chrysalis Biotherapeutics, Inc.
SBIR
2R44AI086135-02
Phase II
2,789,079
sbir.gov/node/388989
‌
Chrysalis BioTherapeutics, Inc. STTR Phase I Award,

A STTR Phase I contract was awarded to Chrysalis Biotherapeutics, Inc. for $300,000.0 USD from the U.S. Department of Health & Human Services.

‌
Chrysalis Biotherapeutics, Inc.
STTR
1R41AI093032-01A1
Phase I
300,000
sbir.gov/node/369945
‌
Chrysalis BioTherapeutics, Inc. SBIR Phase II Award,

A SBIR Phase II contract was awarded to Chrysalis Biotherapeutics, Inc. for $1,499,927.0 USD from the U.S. Department of Health & Human Services.

‌
Chrysalis Biotherapeutics, Inc.
SBIR
N44CA130076
Phase II
1,499,927
sbir.gov/node/679236
‌
Chrysalis BioTherapeutics, Inc. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Chrysalis Biotherapeutics, Inc. for $199,757.0 USD from the U.S. Department of Health & Human Services.

‌
Chrysalis Biotherapeutics, Inc.
SBIR
N43CO110035
Phase I
199,757
sbir.gov/node/372498
‌
Chrysalis BioTherapeutics, Inc. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Chrysalis Biotherapeutics, Inc. for $297,326.0 USD from the U.S. Department of Health & Human Services.

‌
Chrysalis Biotherapeutics, Inc.
SBIR
1R43AI086135-01
Phase I
297,326
sbir.gov/node/12969
6 results
0 selected
6 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us